Monthly Prescribing Reference | New Treanda Formulation Approved Monthly Prescribing Reference Treanda is an alkylating agent currently approved for use in chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin's lymphoma (NHL) that has progressed during or within 6 months of treatment with rituximab or rituximab-containing regimen. |
